Clinical Trial Update: Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients [Phase 1, Phase 2]

View source ↗

Summary

This document reports an update on the safety, tolerability, pharmacokinetics and pharmacodynamics of ADX-038 in healthy participants and Paroxysmal Nocturnal H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• ADX-038

Snippet

Sponsor: ADARx Pharmaceuticals, Inc. | Conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 1, Phase 2 | Status: RECRUITING